Expanding the spectrum of neuronal pathology in multiple system atrophy

Brain

Volumn 138, Issue 8, 2015, Pages 2293-2309

  Cykowski, Matthew D ^a   Coon, Elizabeth A ^b   Powell, Suzanne Z ^a   Jenkins, Sarah M ^b   Benarroch, Eduardo E ^b   Low, Phillip A ^b   Schmeichel, Ann M ^b   Parisi, Joseph E ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

alpha synuclein; inclusion bodies; Lewy body like; multiple system atrophy; neuropathology

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGED; AMBIGUUS NUCLEUS; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; BRAIN; BRAIN NERVE CELL; CAUDATE NUCLEUS; CELL INCLUSION; CEREBELLUM; CEREBELLUM NUCLEUS; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITIVE DEFECT; CORPUS CALLOSUM; CORPUS STRIATUM; DEATH; DENTATE GYRUS; DIAGONAL BAND OF BROCA; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DORSAL RAPHE NUCLEUS; ENTORHINAL CORTEX; FACIAL NERVE NUCLEUS; FEMALE; FOREBRAIN; FRONTAL CORTEX; GLIA CELL; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HYPOGLOSSAL NUCLEUS; HYPOTHALAMUS; INSULA; LATERAL HYPOTHALAMUS; LEWY BODY; LOCUS CERULEUS; MALE; MEDULLARY NUCLEUS; MESENCEPHALON RETICULAR FORMATION; MEYNERT BASAL NUCLEUS; MIDDLE AGED; MORPHOLOGY; MOTONEURON NUCLEUS; NEOCORTEX; NEUROANATOMY; NEUROPATHOLOGY; OCULOMOTOR NUCLEUS; OLFACTORY BULB; OLIVARY NUCLEUS; PERIAQUEDUCTAL GRAY MATTER; PHENOTYPE; PONTINE NUCLEUS; PRIORITY JOURNAL; PUTAMEN; SEPTUM NUCLEUS; SHY DRAGER SYNDROME; SUBCALLOSAL GYRUS; SUBICULUM; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; TECTUM; TEMPORAL LOBE; THALAMUS; THALAMUS LATERAL NUCLEUS; TOPOGRAPHY; TROCHLEAR NUCLEUS; TUBEROMAMMILLARY NUCLEUS; VENTRAL PALLIDUM; VENTRAL STRIATUM; VERY ELDERLY; WHITE MATTER; DIFFUSE LEWY BODY DISEASE; GLIA; METABOLISM; NERVE CELL; PATHOLOGY;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; BRAIN; FEMALE; HUMANS; INCLUSION BODIES; LEWY BODY DISEASE; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEUROGLIA; NEURONS;

EID: 84940062763     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv114     Document Type: Article

References (45)

1. Ahmed Z, Asi YT, Sailer A, Lees AJ, Houlden H, Revesz T, et al. The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol 2012; 38: 4-24.
2. Arai N, Papp MI, Lantos PL. New observation on ubiquitinated neurons in the cerebral cortex of multiple system atrophy (MSA). Neurosci Lett 1994; 182: 197-200.
3. Arima K, Murayama S, Mukoyama M, Inose T. Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 1. Neuronal cytoplasmic inclusions. Acta Neuropathol 1992; 83: 453-60.
4. Armstrong RA, Cairns NJ, Lantos PL. A quantitative study of the pathological changes in ten patients with multiple system atrophy (MSA). J Neural Transm 2004; 111: 485-95.
5. Asi YT, Ling H, Ahmed Z, Lees AJ, Revesz T, Holton JL. Neuropathological features of multiple system atrophy with cognitive impairment. Mov Disord 2014; 29: 884-8.
6. Asi YT, Simpson JE, Heath PR, Wharton SB, Lees AJ, Revesz T, et al. Alpha-synuclein mRNA expression in oligodendrocytes in MSA. Glia 2014; 62: 964-70.
7. Benarroch EE. Brainstem respiratory control: substrates of respiratory failure of multiple system atrophy. Mov Disord 2007; 22: 155-61.
8. Bleasel JM, Hsiao JH, Halliday GM, Kim WS. Increased expression of ABCA8 in multiple system atrophy brain is associated with changes in pathogenic proteins. J Parkinsons Dis 2013; 3: 331-9.
9. Braak H, Del Tredici K, Bohl J, Bratzke H, Braak E. Pathological changes in the parahippocampal region in select non-Alzheimer's dementias. Ann N Y Acad Sci 2000; 911: 221-39.
10. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003a; 24: 197-211.
11. Braak H, Rub U, Del Tredici K. Involvement of precerebellar nuclei in multiple system atrophy. Neuropathol Appl Neurobiol 2003b; 29: 60-76.
12. Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, et al. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 2010; 133: 2382-93.
13. Crosby EC, Humphrey T. Studies of the vertebrate telencephalon. II. The nuclear pattern of the anterior olfactory nucleus, tuberculum olfactorium and the amygdaloid complex in adult man. J Comp Neurol 1941; 74: 309-52.
14. Crosby EC, National Institute on Drug Abuse, Addiction Research Center (US). Correlative anatomy of the nervous system. New York: MacMillan; 1962.
15. Dickson DW, Lin W, Liu WK, Yen SH. Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol 1999a; 9: 721-32.
16. Dickson DW, Liu W, Hardy J, Farrer M, Mehta N, Uitti R, et al. Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol 1999b; 155: 1241-51.
17. Geser F, Malunda JA, Hurtig HI, Duda JE, Wenning GK, Gilman S, et al. TDP-43 pathology occurs infrequently in multiple system atrophy. Neuropathol Appl Neurobiol 2011; 37: 358-65.
18. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71: 670-6.
19. Inoue M, Yagishita S, Ryo M, Hasegawa K, Amano N, Matsushita M. The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems. Acta Neuropathol 1997; 93: 585-91.
20. Iodice V, Lipp A, Ahlskog JE, Sandroni P, Fealey RD, Parisi JE, et al. Autopsy confirmed multiple system atrophy cases: mayo experience and role of autonomic function tests. J Neurol Neurosurg Psychiatry 2012; 83: 453-9.
21. Jellinger KA. More frequent Lewy bodies but less frequent Alzheimer-type lesions in multiple system atrophy as compared to age-matched control brains. Acta Neuropathol 2007; 114: 299-303.
22. Jellinger KA, Seppi K, Wenning GK. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 2005; 20 (Suppl 12): S29-36.
23. Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik RJ, et al. Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 2003; 62: 1087-95.
24. Koziol LF, Budding D, Andreasen N, D'Arrigo S, Bulgheroni S, Imamizu H, et al. Consensus paper: the cerebellum's role in movement and cognition. Cerebellum 2014; 13: 151-77.
25. Lyoo CH, Jeong Y, Ryu YH, Lee SY, Song TJ, Lee JH, et al. Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy. Brain 2008; 131 (Pt 2): 438-46.
26. Miller DW, Cookson MR, Dickson DW. Glial cell inclusions and the pathogenesis of neurodegenerative diseases. Neuron Glia Biol 2004; 1: 13-21.
27. Miller DW, Johnson JM, Solano SM, Hollingsworth ZR, Standaert DG, Young AB. Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J Neural Transm 2005; 112: 1613-24.
28. Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 2012; 123: 1-11.
29. Nelson PT, Schmitt FA, Lin Y, Abner EL, Jicha GA, Patel E, et al. Hippocampal sclerosis in advanced age: clinical and pathological features. Brain 2011; 134 (Pt 5): 1506-18.
30. Ozawa T, Okuizumi K, Ikeuchi T, Wakabayashi K, Takahashi H, Tsuji S. Analysis of the expression level of alpha-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy. Acta Neuropathol 2001; 102: 188-90.
31. Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004; 127 (Pt 12): 2657-71.
32. Pao WC, Dickson DW, Crook JE, Finch NA, Rademakers R, Graff-Radford NR. Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically. Alzheimer Dis Assoc Disord 2011; 25: 364-8.
33. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989; 94: 79-100.
34. Ravits J, Appel S, Baloh RH, Barohn R, Brooks BR, Elman L, et al. Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotroph Lateral Scler Frontotemporal Degener 2013; 14 (Suppl 1): 5-18.
35. Reyes JF, Rey NL, Bousset L, Melki R, Brundin P, Angot E. Alpha-synuclein transfers from neurons to oligodendrocytes. Glia 2014; 62: 387-98.
36. Robinson FR, Straube A, Fuchs AF. Participation of caudal fastigial nucleus in smooth pursuit eye movements. II. Effects of muscimol inactivation. J Neurophysiol 1997; 78: 848-59.
37. Schulz-Schaeffer WJ. The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathol 2010; 120: 131-43.
38. Stankovic I, Krismer F, Jesic A, Antonini A, Benke T, Brown RG, et al. Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group. Mov Disord 2014; 29: 857-67.
39. Stemberger S, Poewe W, Wenning GK, Stefanova N. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure. Exp Neurol 2010; 224: 459-64.
40. Takeda A, Arai N, Komori T, Kato S, Oda M. Neuronal inclusions in the dentate fascia in patients with multiple system atrophy. Neurosci Lett 1997; 227: 157-60.
41. Tang-Wai DF, Knopman DS, Geda YE, Edland SD, Smith GE, Ivnik RJ, et al. Comparison of the short test of mental status and the minimental state examination in mild cognitive impairment. Arch Neurol 2003; 60: 1777-81.
42. Trojanowski JQ, Revesz T. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 2007; 33: 615-20.
43. Ubhi K, Low P, Masliah E. Multiple system atrophy: a clinical and neuropathological perspective. Trends Neurosci 2011; 34: 581-90.
44. Uchikado H, DelleDonne A, Ahmed Z, Dickson DW. Lewy bodies in progressive supranuclear palsy represent an independent disease process. J Neuropathol Exp Neurol 2006; 65: 387-95.
45. Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H. NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol 2000; 99: 14-20.